cbdMD, Inc. (YCBD) Stock Forecast
YCBD analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $2.00 average of analyst targets
- Upside to target
- +461.8% from the latest close
- Next earnings
- —
- 52-week range
- $0.35 – $2.27
YCBD analyst ratings
1 analystsNumber of analysts at each rating.
YCBD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
YCBD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | −$0.06 | −$0.06 | −$0.06 | −$0.04 | −50.0% | 1 |
| Current fiscal year (FY2026) | −$0.33 | −$0.33 | −$0.33 | −$1.09 | +69.7% | 1 |
| Next fiscal year (FY2027) | −$0.19 | −$0.19 | −$0.19 | −$0.33 | +42.4% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
YCBD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $6.3M | $6.3M | $6.3M | +25.5% | 1 |
| Current fiscal year (FY2026) | $21.9M | $21.9M | $21.9M | +14.2% | 1 |
| Next fiscal year (FY2027) | $28.6M | $28.6M | $28.6M | +30.4% | 1 |
YCBD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
YCBD revenue: reported and forecast
YCBD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $0.00 | $0.00 | $0.00 | −$0.10 | −$0.06 | — | 0 up · 0 down |
| Current fiscal year (FY2026) | −$0.19 | −$0.19 | −$0.19 | −$0.33 | −$0.33 | +73.7% | 0 up · 1 down |
| Next fiscal year (FY2027) | −$0.07 | −$0.07 | −$0.07 | −$0.37 | −$0.19 | +171.4% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
YCBD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; YCBD beat in 5 of 12.
What analysts expect from YCBD
1 analysts cover cbdMD; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $2.00, 461.8% above the latest close of $0.36. Analysts expect earnings of −$0.33 per share for FY2026, +69.7% from a year earlier. For FY2027 the average estimate is −$0.19 per share on revenue of $28.6 million. cbdMD beat the EPS estimate in 5 of the last 12 quarters.
Related: YCBD income statement, YCBD key metrics, YCBD chart. See the YCBD stock overview for the latest quote and news.
YCBD forecast FAQ
What is cbdMD's price target?
The average analyst price target for cbdMD is $2.00, 461.8% above the latest close of $0.36.
Is cbdMD a buy, hold or sell?
Of 1 analysts covering cbdMD, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is cbdMD's EPS forecast?
Analysts forecast −$0.33 per share for FY2026 (range −$0.33 to −$0.33); for FY2027 the estimate is −$0.19.
What is cbdMD's revenue forecast?
The average revenue estimate for FY2026 is $21.9 million, growth of 14.2%; for FY2027 it is $28.6 million.
Does cbdMD usually beat earnings estimates?
cbdMD reported EPS at or above the analyst estimate in 5 of the last 12 quarters.